bcbs glp-1 coverage 2026 for obesity treatment in 13 US states' Medicaid programs What Insurance Plans Cover Weight

Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy

Empezar con un GLP-1 es muy parecido a empezar con una estatina, explica Hayes

[18] Common side effects include nausea, loss of appetite, diarrhea, and headaches

It aids digestive regularity, which is crucial given the slowed gastric emptying caused by the medication, helping to manage both constipation and potentially diarrhea (depending on the type of fiber and hydration levels)